Latest News by Industry
DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Thursday reported third-quarter net income of $241.4 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Durham, North Carolina-based company said it had net income of $2.75.
The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $2.10 per share.
The biopharmaceutical company posted revenue of $32.6 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks expected $205.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a CMRX">Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX